Sodium Bicarbonate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Nov 7, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-4916-14
- Dosage Form
- Injection
- Presentation
- Sodium Bicarbonate, Injection, 75 mg/1 mL (NDC 0409-4916-14)
- Initial Posting
- Nov 7, 2025